The gospel of B2B marketing has long preached a simple sermon: explain your product clearly, and the market will reward you.

A phase 1/2 trial shows strong early efficacy for daraxonrasib plus chemotherapy as first-line treatment for patients with metastatic pancreatic cancer — but toxicity is a concern.

UAB School of Optometry researchers have secured a patent for a novel lens design that could slow myopia progression in ...

Saros has raised the bar for the roguelite genre and I don't think I can be satisfied with anything less. Before starting ...

Among 5-year survivors in the tebentafusp arm, 44% received tebentafusp as their only therapy. In contrast, 86% of control ...

As SNS celebrates two decades of discovery, its story is far from complete. Building on the foundation of reliability, power ...

Even as Pakistan has denied any involvement in the Pahalgam terror attack over the past 48 hours, emerging evidence points to ...

Large-scale, high-volume weaving solutions featuring 5,000-7,000 carbon fiber bobbins will aid in advancing aircraft ...

Study published in SCIE-indexed international journal Molecular NeurobiologyThree intravenous infusions at four-week intervals showed benefits in cognition, brain metabolism, and structural ...

The principle of progressive overload is one of the most important aspects of getting results from exercise. Here's what ...

Are these everyday habits secret cancer shields? Healthy lifestyle habits are often promoted for cancer prevention, with ...

Emily, from Kilkenny, has Friedreich's ataxia, a rare disease that progresses over time and affects everything from her ...